Focused Ultrasound Can Lessen Cancer Pain
By MedImaging International staff writers Posted on 19 May 2014 |
Image: Day of treatment pre- and post-procedure MR imaging. Axial T1-weighted contrast-enhanced MR images demonstrating a right ischial metastasis (black arrow) before treatment (left) and immediately after magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment (right). The post-treatment image shows nonenhancement of the lesion, which was targeted from a posterior approach. Each hash mark on the scale bars represents 1 cm (Photo courtesy of Journal of the US National Cancer Institute (JNCI)).
When cancer advances and metastasizes to the bone, patients often suffer debilitating pain. Now, a new phase III clinical trial shows that noninvasive magnetic resonance-guided focused ultrasound treatment that heats the cancer within the bone relieves pain and improves function for most patients when other treatment alternatives are limited.
The study’s findings were first published online April 23, 2014, in the Journal of the National Cancer Institute (JNCI).Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a technique that is been safely used to treat thousands of women with uterine fibroids. However, “this is the first phase III study to use this technology in the treatment of cancer,” noted the study’s principal investigator and lead author Mark Hurwitz, MD, vice chairman of quality, safety, and performance and director of thermal oncology in the department of radiation oncology at Thomas Jefferson University (Philadelphia, PA, USA).
Although radiotherapy is typically used to treat bone-related pain and effective for most patients, not all patients experience pain relief and over time those who do may have recurrence of pain. In addition, it's possible for a patient to receive the maximum radiation dose that can be safely delivered without fully controlling the pain. In situations where radiation therapy is not an option, alternative treatments are required.
A total of 147 patients from 17 centers in the US, Canada, Israel, Italy, and Russia were enrolled in the study and randomized to undergo MRgFUS or a sham treatment. Patients in the treatment group received focused ultrasound precisely targeted to their bone tumors to heat the tumor tissue to between 65 °C and 85 °C, resulting in its obliteration. During each treatment, the patients were tracked real-time via magnetic resonance imaging (MRI) to make sure the appropriate tissue was targeted and the right temperatures were reached while ensuring heat in surrounding normal tissues and organs remained at safe levels. The control group underwent the same procedure but without the ultrasound device turned on. Finally, patients who did not respond to the placebo treatment within two weeks were allowed to be unblinded and offered MRgFUS.
Patients responded well to treatment, with 64% experiencing either no pain or a significant reduction in their pain at three months as gauged by a 2 point or greater decrease in the numeric rating score (NRS) for pain, a clinically validated measurement tool. Many patients were able to reduce or stop use of opiod medications. Significantly, most patients experienced pain relief and improved functioning within several days of treatment. “It’s clear that for many of these patients, pain has a major impact on their everyday lives," says Dr. Hurwitz. “This approach offers a new way to help alleviate that pain via an out-patient noninvasive procedure.”
The next phase in this research, according to Dr. Hurwitz, is to modify the treatment technique to get an even greater response rate, and to apply radiation and thermal therapy together in treatment of bone metastases noting the established clinical benefits for other malignant conditions with this combination. To achieve this, Dr. Jefferson has established a new program for thermal oncology within its department of radiation oncology to provide patients with access to thermal therapies that have been shown to augment radiation treatment.
“The work provides cancer patients with more options for treatment of cancer pain and the opportunity for patients to reduce opioid use, which has significant side effects,” said Adam Dicker, MD, PhD, chair of Jefferson’s department of radiation oncology, and not involved in the study.
Related Links:
Thomas Jefferson University
The study’s findings were first published online April 23, 2014, in the Journal of the National Cancer Institute (JNCI).Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a technique that is been safely used to treat thousands of women with uterine fibroids. However, “this is the first phase III study to use this technology in the treatment of cancer,” noted the study’s principal investigator and lead author Mark Hurwitz, MD, vice chairman of quality, safety, and performance and director of thermal oncology in the department of radiation oncology at Thomas Jefferson University (Philadelphia, PA, USA).
Although radiotherapy is typically used to treat bone-related pain and effective for most patients, not all patients experience pain relief and over time those who do may have recurrence of pain. In addition, it's possible for a patient to receive the maximum radiation dose that can be safely delivered without fully controlling the pain. In situations where radiation therapy is not an option, alternative treatments are required.
A total of 147 patients from 17 centers in the US, Canada, Israel, Italy, and Russia were enrolled in the study and randomized to undergo MRgFUS or a sham treatment. Patients in the treatment group received focused ultrasound precisely targeted to their bone tumors to heat the tumor tissue to between 65 °C and 85 °C, resulting in its obliteration. During each treatment, the patients were tracked real-time via magnetic resonance imaging (MRI) to make sure the appropriate tissue was targeted and the right temperatures were reached while ensuring heat in surrounding normal tissues and organs remained at safe levels. The control group underwent the same procedure but without the ultrasound device turned on. Finally, patients who did not respond to the placebo treatment within two weeks were allowed to be unblinded and offered MRgFUS.
Patients responded well to treatment, with 64% experiencing either no pain or a significant reduction in their pain at three months as gauged by a 2 point or greater decrease in the numeric rating score (NRS) for pain, a clinically validated measurement tool. Many patients were able to reduce or stop use of opiod medications. Significantly, most patients experienced pain relief and improved functioning within several days of treatment. “It’s clear that for many of these patients, pain has a major impact on their everyday lives," says Dr. Hurwitz. “This approach offers a new way to help alleviate that pain via an out-patient noninvasive procedure.”
The next phase in this research, according to Dr. Hurwitz, is to modify the treatment technique to get an even greater response rate, and to apply radiation and thermal therapy together in treatment of bone metastases noting the established clinical benefits for other malignant conditions with this combination. To achieve this, Dr. Jefferson has established a new program for thermal oncology within its department of radiation oncology to provide patients with access to thermal therapies that have been shown to augment radiation treatment.
“The work provides cancer patients with more options for treatment of cancer pain and the opportunity for patients to reduce opioid use, which has significant side effects,” said Adam Dicker, MD, PhD, chair of Jefferson’s department of radiation oncology, and not involved in the study.
Related Links:
Thomas Jefferson University
Latest Ultrasound News
- Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease
- Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions
- First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
- Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions